hi Makis,
Regarding medication for you mother:
The FAD had approved new medication for advanced kidney cancer made by the pharmaceutical company name Novaetis. The drug is Afinitor [everolimus]. This drug is in phase III trail and received its approval as a second – line treatment when treatment has failed with sutunt [sunitinib] and nexavar[ sorafenib].
Afinitor is an oral mTOR [mammalian target of rapamycin] inhibitor that blocks cellular metabolism, growth, proliferation and angiogenesis.
Novartis has filed for Afinitor for approval in EU and Japan. According to an article in farmafocus, the same drug is used in EU under the name of Certican for the management of organ transplant rejection.
I hope this information helps you. I am sure that Novartis has a representative in Greece. If not you can send an e-mail to the head quarter in Switzerland and many a time their representative will call you. I have experience with them already about a different drug.
Best of luck
Keep in touch